1. Home
  2. MLSS vs VTGN Comparison

MLSS vs VTGN Comparison

Compare MLSS & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Milestone Scientific Inc.

MLSS

Milestone Scientific Inc.

HOLD

Current Price

$0.41

Market Cap

22.1M

Sector

Health Care

ML Signal

HOLD

Logo VistaGen Therapeutics Inc.

VTGN

VistaGen Therapeutics Inc.

HOLD

Current Price

$0.24

Market Cap

25.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLSS
VTGN
Founded
1989
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.1M
25.3M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
MLSS
VTGN
Price
$0.41
$0.24
Analyst Decision
Buy
Hold
Analyst Count
1
3
Target Price
$1.00
$0.90
AVG Volume (30 Days)
170.2K
4.1M
Earning Date
05-14-2026
06-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,973,982.00
N/A
Revenue This Year
$12.64
$124.49
Revenue Next Year
$8.99
$353.99
P/E Ratio
N/A
N/A
Revenue Growth
3.99
N/A
52 Week Low
$0.22
$0.20
52 Week High
$0.68
$5.14

Technical Indicators

Market Signals
Indicator
MLSS
VTGN
Relative Strength Index (RSI) 59.36 31.15
Support Level $0.24 $0.20
Resistance Level $0.44 $0.66
Average True Range (ATR) 0.03 0.02
MACD 0.01 -0.00
Stochastic Oscillator 66.86 39.06

Price Performance

Historical Comparison
MLSS
VTGN

About MLSS Milestone Scientific Inc.

Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.

Share on Social Networks: